These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 26775556)
1. Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy. Wang J; Duan L; Guo T; Gao Y; Tian L; Liu J; Wang S; Yang J J Diabetes Complications; 2016 Apr; 30(3):406-14. PubMed ID: 26775556 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice. Wang J; Duan L; Gao Y; Zhou S; Liu Y; Wei S; An S; Liu J; Tian L; Wang S Mol Cell Endocrinol; 2018 Sep; 472():149-158. PubMed ID: 29233785 [TBL] [Abstract][Full Text] [Related]
3. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
4. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810 [TBL] [Abstract][Full Text] [Related]
5. The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy. Zheng Z; Guan M; Jia Y; Wang D; Pang R; Lv F; Xiao Z; Wang L; Zhang H; Xue Y Sci Rep; 2016 Nov; 6():37492. PubMed ID: 27874055 [TBL] [Abstract][Full Text] [Related]
6. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice. Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848 [TBL] [Abstract][Full Text] [Related]
7. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy. Gao BH; Wu H; Wang X; Ji LL; Chen C Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183 [TBL] [Abstract][Full Text] [Related]
8. Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy. Wang J; Duan L; Tian L; Liu J; Wang S; Gao Y; Yang J Exp Clin Endocrinol Diabetes; 2016 Jul; 124(7):417-23. PubMed ID: 26575121 [TBL] [Abstract][Full Text] [Related]
9. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p. Fu JX; Sun GQ; Wang HL; Jiang HX J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534 [TBL] [Abstract][Full Text] [Related]
10. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1. Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy. Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy. Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3. Liu C; Zhuo H; Ye MY; Huang GX; Fan M; Huang XZ Kaohsiung J Med Sci; 2020 Sep; 36(9):682-691. PubMed ID: 32391974 [TBL] [Abstract][Full Text] [Related]
14. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway. Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506 [TBL] [Abstract][Full Text] [Related]
15. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928 [TBL] [Abstract][Full Text] [Related]
16. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587 [TBL] [Abstract][Full Text] [Related]
17. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells. Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323 [TBL] [Abstract][Full Text] [Related]
18. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis. Liu B; Qiang L; Wang GD; Duan Q; Liu J Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103 [TBL] [Abstract][Full Text] [Related]
20. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy. Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]